Identification of FDA-approved Drugs That Computationally Bind to MDM2

Chemical Biology and Drug Design - United Kingdom
doi 10.1111/j.1747-0285.2012.01428.x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Possible FDA-approved Drugs to Treat Ebola Virus Infection

Infectious Diseases of Poverty
MedicineEnvironmentalPublic HealthInfectious DiseasesOccupational Health
2015English

Repurposing FDA-approved Drugs for Anti-Aging Therapies

Biogerontology
AgingGerontologyGeriatrics
2016English

Identification of FDA Approved Drugs Targeting COVID-19 Virus by Structure-Based Drug Repositioning

2020English

Identification of FDA-approved Drugs Targeting Breast Cancer Stem Cells Along With Biomarkers of Sensitivity

Scientific Reports
Multidisciplinary
2013English

Chemical Screen Identifies FDA-approved Drugs and Target Pathways That Induce Precocious Pancreatic Endocrine Differentiation

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2011English

Quantitative Analysis on the Characteristics of Targets With FDA Approved Drugs

International Journal of Biological Sciences
Applied MicrobiologyEvolutionEcologyDevelopmental BiologyCell BiologyMolecular BiologySystematicsBehaviorBiotechnology
2008English

Repurposing FDA-approved Drugs as Therapeutics to Treat Rift Valley Fever Virus Infection

Frontiers in Microbiology
Microbiology
2015English

A Review on the Drugs Approved by US-FDA and DCGI

TEXILA INTERNATIONAL JOURNAL OF CLINICAL RESEARCH
2016English

Identification of NUDT5 Inhibitors From Approved Drugs

Frontiers in Molecular Biosciences
BiochemistryGeneticsMolecular Biology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy